Project Outlier is an immersive consulting firm catering exclusively to the biotech and pharma industries. Their services encompass project management, program management, PMO, process improvement, business analysis, and service development. Their track record includes assisting startups in launching their first FDA-approved therapies, aiding globally recognized brands in monumental business transformations, and supporting clinical-to-commercial clients in enhancing foundational capabilities to drive growth. Founded in 2012, Project Outlier prides itself on tailoring strategies and teams to address each client's unique needs, emphasizing that no problem is too large or small for their expertise. For those in the biotech and pharma sectors seeking to plan and execute critical business and technology transformation projects, Project Outlier's analytics-focused approach stands as a potential resource for their success. For further inquiries, interested parties can reach out to Project Outlier via their official website.
There is no investment information
No recent news or press coverage available for Project Outlier.